LEIDOS BIOMEDICAL RESEARCH INC - IGF::OT::IGF RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS
Key Details
Description
IGF::OT::IGF RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS
Context & Analysis
On Feb 23, 2026, Department of Health and Human Services obligated $19,759,807 to LEIDOS BIOMEDICAL RESEARCH INC for igf::ot::igf retrospective tumor characterization analysis. The award is classified under NAICS 561210 — FACILITIES SUPPORT SERVICES and issued as a cost plus fixed fee contract. Competition extent: not competed. Performance is located in FREDERICK, MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 561210 — related awards are listed below.
Market context
- Recompete outlook
- Ended Sep 30, 2026 (22 days ago). Recompete signal as of Oct 20, 2026: 64/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Not competed. 46% of 270 awards in this market (Department of Health and Human Services awards in NAICS 561210 over the last 3 years) were competed; median 1 offers.
- Award size
- At $19.8M, this award is larger than 19 in 20 of the 276 priced Department of Health and Human Services awards in NAICS 561210 over the last 3 years (median $91K).
- Incumbent at this agency
- LEIDOS BIOMEDICAL RESEARCH INC has 69 other awards from Department of Health and Human Services, totalling $3.0B, 2016–2026.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 561210 over the last 3 years.
- FOUR SEASONS ENVIRONMENTAL INC — 5 awards, $98.2M
- NANA REGIONAL CORPORATION, INC. — 11 awards, $39.3M
- NVT TECHNOLOGIES INC — 2 awards, $30.2M
- APEX FSE JV LLC — 1 award, $26.7M
- PER-GEESH CONSTRUCTION CORPORATION — 3 awards, $24.4M
Computed from USAspending award data on Oct 20, 2026.
Contractor Information
Similar Awards
IGF::OT::IGF MANAGEMENT, OPERATION, PROFESSIONAL, AND TECHNICAL SUPPORT SERVICES FOR NIAID ANIMAL CARE FACILITIES
CHARLES RIVER LABORATORIES, INC.
$112.0M
HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23
LEIDOS BIOMEDICAL RESEARCH INC
$72.3M
ATLANTA OM
FOUR SEASONS ENVIRONMENTAL INC
$51.0M
ATLANTA OM
FOUR SEASONS ENVIRONMENTAL INC
$46.9M
IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS ? BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)
LEIDOS BIOMEDICAL RESEARCH INC
$27.5M
Stay Updated
Get notified about new opportunities matching your interests.